It is a GLP-1 receptor agonist and works by stimulating insulin secretion, suppressing glucagon secretion, reducing appetite, and slowing gastric emptying
T-CD4 + lymphocyte activation can generate some profiles (named Th), which depend on molecules present in the microenvironment
Authors contributions AR and PB designed the trial and collected the data, AR, AL and PB treated the patients and organized the trial, PB did the statistical analysis and wrote the manuscript
Kurgan , nder C, Altngz SM, Ba N, Uyank M, Serdar MA, Kantarc A
Lifestyle changes like diet and exercise can help preserve some benefits of GLP-1s, but they can't replace all of the medication's effects